Form 4 Filing for Alaunos Therapeutics, Inc.

Holger Weis, Chief Executive Officer of Alaunos Therapeutics, Inc., acquired 3700 shares of common stock on May 22, 2026. The acquisition was part of a salary payment, with shares valued at $2.37 each. Following this transaction, Weis now owns 4911 shares of common stock. The filing, designated as Form 4, was signed on May 27, 2026.